YM-266183 and YM-266184, Novel Thiopeptide Antibiotics Produced by Bacillus cereus Isolated from a Marine Sponge. II. Structure Elucidation.

Ken‐ichi Suzumura, Takako Yokoi, Masashi Funatsu, Koji Nagai, Kōichi Tanaka, Huiping Zhang, Kenichi SuzukiThe Journal of Antibiotics 2003 · DOI

Introduction

The global rise of multi-drug resistant "superbugs" has created an urgent need for novel antibiotic classes. Among the most promising candidates are thiopeptides, a family of potent natural products known for their complex, sulfur-rich cyclic structures. However, their sheer size and chemical intricacy make them notoriously difficult to characterize.

Researchers have recently isolated two new thiopeptide antibiotics, YM-266183 and YM-266184, from a strain of Bacillus cereus (QN03323) found within a marine sponge. This discovery highlights marine environments as rich reservoirs of unique microbial chemistry. This paper details the rigorous structure elucidation process required to map these massive molecules, a critical step toward understanding their biological function and potential therapeutic use.

Solving the Structural Puzzle

Determining the precise 3D arrangement of atoms in a thiopeptide is a significant challenge. The researchers employed a combination of high-resolution Mass Spectrometry (MS) and advanced Nuclear Magnetic Resonance (NMR) spectroscopy. While standard 1D and 2D NMR techniques provided initial clues, the complexity of these molecules—characterized by overlapping signals in the carbon-13 ($^{13}C$) spectrum—necessitated more specialized tools.

The team utilized Constant Time HMBC (CT-HMBC) to overcome these hurdles. Standard Heteronuclear Multiple Bond Correlation (HMBC) can suffer from signal interference (J-modulation) in crowded spectra. CT-HMBC improves resolution and eliminates these artifacts, allowing for unambiguous mapping of long-range carbon-proton connectivities.

Figure 2: NMR correlation map showing COSY (bold lines) and HMBC (arrows) interactions used to define substructures A, B, C, and D.

As shown in Figure 2, the researchers divided the molecule into four distinct substructures (A-D). By tracing the correlations between atoms, they were able to demonstrate how these fragments link together to form the final macrocyclic architecture.

Chemical Architecture and Key Insights

The structural analysis revealed that YM-266183 and YM-266184 are cyclic thiopeptides containing a central trisubstituted pyridine ring and four thiazole rings. A defining feature of these compounds is the inclusion of "unusual" amino acids not found in standard proteins, such as 3-hydroxyvaline, amino acetone, and 2-amino-2-butenoic acid. These building blocks are integral to maintaining the molecule's rigid, bioactive shape.

Figure 1: The complete chemical structure of YM-266183, showing the complex arrangement of thiazole and pyridine rings.

One of the most subtle yet important findings was the "methoxy switch." YM-266183 features a hydroxy group ($-OH$) at a specific position, while YM-266184 contains a methoxy group ($-OCH_3$). Despite this minor difference, a full secondary NMR analysis was required to confirm the substitution. Furthermore, the researchers determined the specific (Z)-geometry of the double bonds, a spatial orientation that is often critical for an antibiotic's ability to bind to its bacterial target.

Results and Future Directions

The final elucidated structures are as follows:

  • YM-266183: $C_{48}H_{47}N_{13}O_{10}S_6$ (Molecular weight: 1158)
  • YM-266184: $C_{49}H_{49}N_{13}O_{10}S_6$ (Molecular weight: 1172)

The molecules form a large macrocycle closed by an amide bond between a thiazole methine and a carbonyl group. While this study focuses on the chemical "map," the compounds have already shown activity against drug-resistant bacteria.

Future research will focus on "Total Synthesis"—building these complex molecules from scratch in the laboratory—and Structure-Activity Relationship (SAR) studies. By systematically modifying the structure, scientists hope to enhance antibiotic potency, reduce potential toxicity, and eventually move toward animal models and clinical trials. This work represents a vital step in the ongoing battle against antibiotic resistance, turning a marine-derived mystery into a potential medical breakthrough.

Summary updated

Abstract

YM-266183 and YM-266184 are new antibacterial substances that have activity against drug-resistant bacteria produced by Bacillus cereus QN03323. These structures were elucidated by MS and NMR spectral analysis. YM-266183 and YM-266184 are the cyclic thiopeptides containing thiazole and pyridine moieties, and several unusual amino acids.
BibTeX
@article{suzumura2003ym,
  author = {Ken‐ichi Suzumura and Takako Yokoi and Masashi Funatsu and Koji Nagai and Kōichi Tanaka and Huiping Zhang and Kenichi Suzuki},
  title = {{YM-266183 and YM-266184, Novel Thiopeptide Antibiotics Produced by Bacillus cereus Isolated from a Marine Sponge. II. Structure Elucidation.}},
  journal = {The Journal of Antibiotics},
  year = {2003},
  doi = {10.7164/antibiotics.56.129},
}
Figure